Source:http://linkedlifedata.com/resource/pubmed/id/16952411
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2007-10-23
|
pubmed:abstractText |
Presenilin-1 (PSEN-1) is a component of the gamma-secretase complex involved in beta-amyloid precursor protein (betaAPP) processing. To date about 140 pathogenic mutations in the PSEN-1 gene have been identified and their main biochemical effect is to increase the production of the fibrillogenic peptide Abeta(1-42). An exception is the PSEN-1 [E318G] mutation that does not alter Abeta(1-42) generation and is generally considered a non-pathogenic polymorphism. Nevertheless, this mutation was reported to be a genetic risk factor for familial Alzheimer's disease (FAD) in the Australian population. To independently confirm this indication, we performed a case-control association study in the Italian population. We found a significant association (p<0.05, Fisher's exact test) between the presence of PSEN-1 [E318G] and FAD. In addition, on measuring the Abeta(1-42) and Abeta(1-40) concentrations in fibroblast-conditioned media cultured from PSEN-1 [E318G] carriers and PSEN-1 [wild type] controls we noted a significant decrease (p<0.05, Mann-Whitney test) in the Abeta(1-42)/Abeta(1-40) ratio in PSEN-1 [E318G] carriers, suggesting a peculiar biochemical effect of this mutation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1558-1497
|
pubmed:author |
pubmed-author:AlbaniDiegoD,
pubmed-author:ArtusoVladimiroV,
pubmed-author:BatelliSaraS,
pubmed-author:BruniAmaliaA,
pubmed-author:ConfaloniAnnamariaA,
pubmed-author:ForloniGianluigiG,
pubmed-author:FranceschiMassimoM,
pubmed-author:GalimbertiDanielaD,
pubmed-author:PesaresiMarziaM,
pubmed-author:PirasMaria RitaMR,
pubmed-author:PratoFrancescaF,
pubmed-author:RoiterIgnazioI,
pubmed-author:ScarpiniElioE
|
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1682-8
|
pubmed:meshHeading |
pubmed-meshheading:16952411-Aged,
pubmed-meshheading:16952411-Aged, 80 and over,
pubmed-meshheading:16952411-Alzheimer Disease,
pubmed-meshheading:16952411-Amino Acid Substitution,
pubmed-meshheading:16952411-Case-Control Studies,
pubmed-meshheading:16952411-Female,
pubmed-meshheading:16952411-Glutamic Acid,
pubmed-meshheading:16952411-Glycine,
pubmed-meshheading:16952411-Heterozygote Detection,
pubmed-meshheading:16952411-Humans,
pubmed-meshheading:16952411-Italy,
pubmed-meshheading:16952411-Male,
pubmed-meshheading:16952411-Middle Aged,
pubmed-meshheading:16952411-Mutation,
pubmed-meshheading:16952411-Pedigree,
pubmed-meshheading:16952411-Presenilin-1
|
pubmed:year |
2007
|
pubmed:articleTitle |
Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population.
|
pubmed:affiliation |
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, via Eritrea 62, 20157 Milan, Italy. albani@marionegri.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|